PET plus CT was better than conventional methods for correctly upstaging early NSCLC

Irion, Klaus L.
December 2009
ACP Journal Club;12/15/2009, Vol. 151 Issue 6, p8
Academic Journal
The article presents information about a clinical trial which focuses on the effectiveness of positron emission tomography plus computed tomography (PET-CT) for correctly upstaging early non-small-cell lung cancer (NSCLC). 337 patients with histologically or cytologically confirmed clinical stage I to IIIA NSCLC were selected from 8 hospitals and 5 PET-CT centers in Ontario, Canada. The results show that PET-CT was better than conventional methods for correctly upstaging the disease.


Related Articles

  • The power of synergy in the mediastinal staging of lung cancer. Lucignani, Giovanni // European Journal of Nuclear Medicine & Molecular Imaging;Jul2008, Vol. 35 Issue 7, p1388 

    The article focuses on the mediastinal staging of lung cancer. It states that positron emission tomography and computed tomography should play a role in the clinical staging of all lung cancer patients because it can provide an initial estimate of the burden of the whole body. It mentions that...

  • Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application. Seemann, Marcus D.; Schaefer, Juergen F.; Englmeier, Karl-Hans // European Radiology;Mar2007, Vol. 17 Issue 3, p709 

    The aim of this study was to demonstrate the possibilities, advantages and limitations of virtual bronchoscopy using data sets from positron emission tomography (PET) and computed tomography (CT). Twelve consecutive patients with lung cancer underwent PET/CT. PET was performed with F-18-labelled...

  • Increase in survival for advanced lung cancer attributed to stage migration.  // Hem/Onc Today;9/10/2008, Vol. 9 Issue 16, p22 

    The article discusses research being done on the effect of the use of positron emission tomography (PET) on the survival rate of lung cancer patients. It references a study which appeared in the 2008 issue of "Archives of Internal Medicine." The researchers examined patients from 1994 to 1998...

  • Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation. Hany, Thomas F.; Heuberger, Juerg; von Schulthess, Gustav K. // European Radiology;Sep2003, Vol. 13 Issue 9, p2122 

    2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) has become an important staging modality for many tumors, including bronchial carcinoma; however it is important to know that there are several pitfalls in PET image interpretation. In this report we demonstrate three...

  • Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT. Yon Sung; Kyung Lee; Byung-Tae Kim; Joungho Han; Eun Lee // European Radiology;Oct2005, Vol. 15 Issue 10, p2075 

    We present a case of bronchioloalveolar carcinoma manifesting as air-space consolidation with negative FDG uptake on integrated PET/CT in a 42-year-old woman. To know this pattern of uptake especially in the case of mucin-predominant lobar bronchioloalveolar carcinoma may help avoid misdiagnosis...

  • Integrated positron emission tomography/computed tomography fusion imaging: An emerging gold standard in lung cancer. Joshi, S. C.; Pant, I.; Hamzah, F.; Kumar, G; Shukla, A. N. // Indian Journal of Cancer;Oct-Dec2008, Vol. 45 Issue 4, p137 

    Positron emission tomography (PET) has emerged as an important diagnostic tool in the management of lung cancers. Although PET is sensitive in detection of lung cancer, but FDG (2-deoxy-2-18fluro-D-glucose) is not tumor specific and may accumulate in a variety of nonmalignant conditions...

  • Disseminated iodine-avid lung metastases in differentiated thyroid cancer: a challenge to 124I PET. Freudenberg, Lutz S.; Jentzen, Walter; Müller, Stefan P.; Bockisch, Andreas // European Journal of Nuclear Medicine & Molecular Imaging;Mar2008, Vol. 35 Issue 3, p502 

    This study assessed the ability of visual and quantitative 124-iodine positron emission tomography (124I PET) data to detect disseminated iodine-avid lung metastases (DILM) of differentiated thyroid cancer (DTC). Using “post-therapy” 131-iodine (131I) whole-body scintigraphy (TxWBS)...

  • The Myth of Multimodality Diagnostic Agents. Frangioni, John V. // Molecular Imaging;Mar/Apr2011, Vol. 10 Issue 2, p79 

    No abstract available.

  • PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. Soloviev, Dmitri; Fini, Alberto; Chierichetti, Franca; Al-Nahhas, Adil; Rubello, Domenico // European Journal of Nuclear Medicine & Molecular Imaging;May2008, Vol. 35 Issue 5, p942 

    In the present study, the potential clinical role of 11C-acetate PET mainly in the differential diagnosis, in the staging and in the follow-up of prostate cancer patients is reported. Each of the above points has been accurately investigated by studying the specific biochemical and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics